These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

709 related items for PubMed ID: 9361306

  • 1. The immunosuppressant drug FK506 ameliorates secondary mitochondrial dysfunction following transient focal cerebral ischemia in the rat.
    Nakai A, Kuroda S, Kristián T, Siesjö BK.
    Neurobiol Dis; 1997; 4(3-4):288-300. PubMed ID: 9361306
    [Abstract] [Full Text] [Related]

  • 2. Delayed treatment with alpha-phenyl-N-tert-butyl nitrone (PBN) attenuates secondary mitochondrial dysfunction after transient focal cerebral ischemia in the rat.
    Kuroda S, Katsura K, Hillered L, Bates TE, Siesjö BK.
    Neurobiol Dis; 1996 Apr; 3(2):149-57. PubMed ID: 9173922
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effect of the immunosuppressant drug FK506 on neonatal cerebral mitochondrial function and energy metabolism after transient intrauterine ischemia in rats.
    Shibazaki Y, Nakai A, Koshino T, Yokoyama K.
    Brain Res; 2001 Feb 23; 892(2):351-8. PubMed ID: 11172783
    [Abstract] [Full Text] [Related]

  • 14. Role and mechanisms of secondary mitochondrial failure.
    Siesjö BK, Elmér E, Janelidze S, Keep M, Kristián T, Ouyang YB, Uchino H.
    Acta Neurochir Suppl; 1999 Feb 23; 73():7-13. PubMed ID: 10494335
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Neuroprotective effects of an immunosuppressant agent on diffusion/perfusion mismatch in transient focal ischemia.
    Ebisu T, Mori Y, Katsuta K, Fujikawa A, Matsuoka N, Aoki I, Umeda M, Naruse S, Tanaka C.
    Magn Reson Med; 2004 Jun 23; 51(6):1173-80. PubMed ID: 15170837
    [Abstract] [Full Text] [Related]

  • 18. Effect of NXY-059 on secondary mitochondrial dysfunction after transient focal ischemia; comparison with cyclosporin A.
    Yoshimoto T, Kristián T, Hu B, Ouyang YB, Siesjö BK.
    Brain Res; 2002 Apr 05; 932(1-2):99-109. PubMed ID: 11911866
    [Abstract] [Full Text] [Related]

  • 19. Cerebral energy state, mitochondrial function, and redox state measurements in transient ischemia.
    Rehncrona S, Mela L, Chance B.
    Fed Proc; 1979 Oct 05; 38(11):2489-92. PubMed ID: 488372
    [Abstract] [Full Text] [Related]

  • 20. Multiple modes of action of tacrolimus (FK506) for neuroprotective action on ischemic damage after transient focal cerebral ischemia in rats.
    Furuichi Y, Noto T, Li JY, Oku T, Ishiye M, Moriguchi A, Aramori I, Matsuoka N, Mutoh S, Yanagihara T.
    Brain Res; 2004 Jul 16; 1014(1-2):120-30. PubMed ID: 15212998
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.